Overview / Abstract: |
Target Audience This educational activity is directed toward neurologists and MS subspecialists. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in the treatment and management of patients with MS will be invited to participate. Program Overview Multiple sclerosis (MS) is an inflammatory disorder of the central nervous system characterized by demyelination and neurodegenerative progression. Most patients with MS experience relapses and remission of neurological symptoms, especially early in the disease course. Advances in understanding of the immune mechanisms that contribute to MS have led to the development of many disease-modifying therapies that target effector T cells, regulatory cells, B cells, and cell trafficking into the nervous system. This online on-demand virtual webcast brings together renowned experts in MS. In this activity, 3 key thought leaders explore the latest data regarding current and emerging therapeutic strategies for the management of patients with MS. This lively discussion will help place new developments into clinical context to help you optimize care for your patients with MS. This educational activity is an archive of the live virtual webcast held on December 9, 2021. Learning Objectives Upon completion of this activity, participants should be better able to: Review key clinical trial data for current and emerging therapies for the treatment of MS |
Expiration |
Dec 23, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Chair FACULTY_NAME Faculty FACULTY_NAME FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
Biogen |
Keywords / Search Terms |
Relias LLC Relias LLC., Multiple Sclerosis, FreeCME Free CE CME |